These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28396279)

  • 41. Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus.
    Garcia-Contreras M; Brooks RW; Boccuzzi L; Robbins PD; Ricordi C
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2940-2956. PubMed ID: 28682421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).
    Gallart-Palau X; Serra A; Wong AS; Sandin S; Lai MK; Chen CP; Kon OL; Sze SK
    Sci Rep; 2015 Sep; 5():14664. PubMed ID: 26419333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics.
    Kreimer S; Belov AM; Ghiran I; Murthy SK; Frank DA; Ivanov AR
    J Proteome Res; 2015 Jun; 14(6):2367-84. PubMed ID: 25927954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exosomes: immune properties and potential clinical implementations.
    Chaput N; Théry C
    Semin Immunopathol; 2011 Sep; 33(5):419-40. PubMed ID: 21174094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extracellular Vesicles: How the External and Internal Environment Can Shape Cell-To-Cell Communication.
    Neven KY; Nawrot TS; Bollati V
    Curr Environ Health Rep; 2017 Mar; 4(1):30-37. PubMed ID: 28116555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles.
    Zhang B; Yeo RW; Tan KH; Lim SK
    Int J Mol Sci; 2016 Feb; 17(2):174. PubMed ID: 26861305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Extracellular Membrane Vesicles with Cutaneous Wound Healing.
    Than UTT; Guanzon D; Leavesley D; Parker T
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating extracellular vesicles as a potential source of new biomarkers of drug-induced liver injury.
    Yang X; Weng Z; Mendrick DL; Shi Q
    Toxicol Lett; 2014 Mar; 225(3):401-6. PubMed ID: 24462978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct detection of two different tumor-derived extracellular vesicles by SAM-AuNIs LSPR biosensor.
    Thakur A; Qiu G; Ng SP; Guan J; Yue J; Lee Y; Wu CL
    Biosens Bioelectron; 2017 Aug; 94():400-407. PubMed ID: 28324860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment.
    Hosseini-Beheshti E; Choi W; Weiswald LB; Kharmate G; Ghaffari M; Roshan-Moniri M; Hassona MD; Chan L; Chin MY; Tai IT; Rennie PS; Fazli L; Tomlinson Guns ES
    Oncotarget; 2016 Mar; 7(12):14639-58. PubMed ID: 26840259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ciliary Extracellular Vesicles: Txt Msg Organelles.
    Wang J; Barr MM
    Cell Mol Neurobiol; 2016 Apr; 36(3):449-57. PubMed ID: 26983828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of vector-borne infectious diseases by human immunity against α-Gal.
    Cabezas Cruz A; Valdés JJ; de la Fuente J
    Expert Rev Vaccines; 2016 Aug; 15(8):953-5. PubMed ID: 27100121
    [No Abstract]   [Full Text] [Related]  

  • 53. Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers.
    Roberson CD; Atay S; Gercel-Taylor C; Taylor DD
    Cancer Biomark; 2010-2011; 8(4-5):281-91. PubMed ID: 22045359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel 3D heterotypic spheroid model for studying extracellular vesicle-mediated tumour and immune cell communication.
    Sadovska L; Zandberga E; Sagini K; Jēkabsons K; Riekstiņa U; Kalniņa Z; Llorente A; Linē A
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1930-1935. PubMed ID: 29248729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells.
    Lopes-Rodrigues V; Di Luca A; Sousa D; Seca H; Meleady P; Henry M; Lima RT; O'Connor R; Vasconcelos MH
    Biochim Biophys Acta; 2016 Mar; 1860(3):618-27. PubMed ID: 26708992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of exosomes and miRNAs in drug-resistance of cancer cells.
    Bach DH; Hong JY; Park HJ; Lee SK
    Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging technologies in extracellular vesicle-based molecular diagnostics.
    Jia S; Zocco D; Samuels ML; Chou MF; Chammas R; Skog J; Zarovni N; Momen-Heravi F; Kuo WP
    Expert Rev Mol Diagn; 2014 Apr; 14(3):307-21. PubMed ID: 24575799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic applications of extracellular vesicles: clinical promise and open questions.
    György B; Hung ME; Breakefield XO; Leonard JN
    Annu Rev Pharmacol Toxicol; 2015; 55():439-464. PubMed ID: 25292428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Methods of Choice for Extracellular Vesicles (EVs) Characterization.
    Szatanek R; Baj-Krzyworzeka M; Zimoch J; Lekka M; Siedlar M; Baran J
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular Vesicles in Metabolic Syndrome.
    Martínez MC; Andriantsitohaina R
    Circ Res; 2017 May; 120(10):1674-1686. PubMed ID: 28495997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.